)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Balchem
Balchem (BCPC) investor relations material
Balchem Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary23 Oct, 2026
Executive summary
Record Q3 sales of $290.658M, GAAP net earnings of $46.728M and adjusted EBITDA of $80.3M; all three segments grew sales and operating earnings.
Adjusted EBITDA increased YoY for the 29th consecutive quarter, reflecting portfolio strength and resilience across market conditions.
Financial highlights
Q3 net sales rose 8.6% to $290.658M; operating earnings increased 14.4% to $62.437M, net earnings rose 16.0% to $46.728M and diluted EPS was $1.46.
Adjusted EBITDA grew 12.4% to $80.3M; adjusted net earnings rose 14.5% to $50.4M and adjusted diluted EPS increased 16.3% to $1.57.
Gross profit increased 10.7% to $105.714M; gross margin expanded 70 bps to 36.4%, with growth, favorable mix and manufacturing efficiencies partly offset by higher input costs.
9M sales rose 9.3% to $845.364M; net earnings increased 13.8% to $131.628M, adjusted EBITDA grew 12.4% to $232.5M and adjusted net earnings rose 12.6% to $141.4M.
9M diluted EPS was $4.09 and adjusted diluted EPS was $4.40, up from $3.54 and $3.84, respectively.
Outlook and guidance
Q4 is normally sequentially lower than Q3 due to seasonality; management expected healthy YoY growth to continue.
Human Nutrition & Health outlook remained positive; Animal Nutrition & Health management cited potential for further technology penetration and long-term growth.
Growth priorities include innovation, product launches, market penetration, geographic expansion, adjacent capabilities and targeted M&A.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Balchem
- Record FY2023 adjusted EBITDA and free cash flow offset lower sales.BCPC
Q4 2023 - Record Q2 2026 sales, earnings, and cash flow with robust growth and expanded credit facility.BCPCQ2 2026
- All management proposals passed, including board elections and auditor ratification.BCPCAGM 2026
- Record Q1 2026 sales, earnings, and cash flow with growth across all segments and improved margins.BCPCQ1 2026
- Virtual meeting to vote on directors, auditor, and executive pay set for June 18, 2026.BCPCProxy filing
- Strong 2025 results, board elections, auditor ratification, and performance-based executive pay.BCPCProxy filing
- Record sales, earnings, and cash flow growth, with increased dividends and strong global expansion.BCPCQ4 2025
- Q3 2024 net earnings rose 16.4% on 4.3% higher sales, led by Human Nutrition & Health.BCPCQ3 2024
- Record Q2 earnings and margin gains led by Human Nutrition & Health and Specialty Products.BCPCQ2 2024
Next Balchem earnings date
Q4 202619 Feb, 2027
Balchem
Next Balchem earnings date
Q4 202619 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Balchem Corporation produces specialty ingredients and performance products for human nutrition, animal nutrition, and industrial markets. Its operations span food fortification, dietary supplements, feed additives, and specialty chemicals used in manufacturing processes. The company provides solutions that support health, wellness, and functional performance across diverse applications. The company is headquartered in Montvale, New Jersey, and its shares are listed on the NASDAQ.